vs
科睿唯安（CLVT）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是科睿唯安的1.2倍（$719.4M vs $585.5M），Healthpeak Properties净利率更高（73.2% vs -6.9%，领先80.0%），Healthpeak Properties同比增速更快（3.1% vs -1.4%），Healthpeak Properties自由现金流更多（$357.0M vs $78.9M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -5.1%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CLVT vs DOC — 直观对比
营收规模更大
DOC
是对方的1.2倍
$585.5M
营收增速更快
DOC
高出4.4%
-1.4%
净利率更高
DOC
高出80.0%
-6.9%
自由现金流更多
DOC
多$278.1M
$78.9M
两年增速更快
DOC
近两年复合增速
-5.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $719.4M |
| 净利润 | $-40.2M | $114.0M |
| 毛利率 | 67.2% | — |
| 营业利润率 | 5.2% | 17.4% |
| 净利率 | -6.9% | 73.2% |
| 营收同比 | -1.4% | 3.1% |
| 净利润同比 | 61.3% | 2406.4% |
| 每股收益（稀释后） | $-0.06 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTDOC
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $719.4M | ||
| Q3 25 | $623.1M | $705.9M | ||
| Q2 25 | $621.4M | $694.3M | ||
| Q1 25 | $593.7M | $702.9M | ||
| Q4 24 | $663.0M | $698.0M | ||
| Q3 24 | $622.2M | $700.4M | ||
| Q2 24 | $650.3M | $695.5M |
净利润CLVTDOC
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $114.0M | ||
| Q3 25 | $-28.3M | $-117.1M | ||
| Q2 25 | $-72.0M | $31.7M | ||
| Q1 25 | $-103.9M | $42.8M | ||
| Q4 24 | $-191.8M | $4.5M | ||
| Q3 24 | $-65.6M | $85.9M | ||
| Q2 24 | $-304.3M | $146.0M |
毛利率CLVTDOC
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | 58.6% | ||
| Q2 25 | 67.2% | 60.2% | ||
| Q1 25 | 65.1% | 61.1% | ||
| Q4 24 | 65.7% | 60.3% | ||
| Q3 24 | 66.2% | 60.0% | ||
| Q2 24 | 67.2% | 60.6% |
营业利润率CLVTDOC
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | 17.4% | ||
| Q3 25 | 7.1% | 9.2% | ||
| Q2 25 | 1.1% | 5.7% | ||
| Q1 25 | -3.5% | 7.7% | ||
| Q4 24 | -9.4% | -2.2% | ||
| Q3 24 | 3.5% | 14.1% | ||
| Q2 24 | -36.9% | 22.3% |
净利率CLVTDOC
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | 73.2% | ||
| Q3 25 | -4.5% | -16.6% | ||
| Q2 25 | -11.6% | 4.6% | ||
| Q1 25 | -17.5% | 6.1% | ||
| Q4 24 | -28.9% | 0.7% | ||
| Q3 24 | -10.5% | 12.3% | ||
| Q2 24 | -46.8% | 21.0% |
每股收益（稀释后）CLVTDOC
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $0.16 | ||
| Q3 25 | $-0.04 | $-0.17 | ||
| Q2 25 | $-0.11 | $0.05 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | $-0.27 | $0.02 | ||
| Q3 24 | $-0.09 | $0.12 | ||
| Q2 24 | $-0.46 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $467.5M |
| 总债务越低越好 | $4.3B | $9.8B |
| 股东权益账面价值 | $4.8B | $7.5B |
| 总资产 | $10.9B | $20.3B |
| 负债/权益比越低杠杆越低 | 0.89× | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资CLVTDOC
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $467.5M | ||
| Q3 25 | $318.7M | $91.0M | ||
| Q2 25 | $362.6M | $89.4M | ||
| Q1 25 | $354.0M | $70.6M | ||
| Q4 24 | $295.2M | $119.8M | ||
| Q3 24 | $388.5M | $180.4M | ||
| Q2 24 | $376.4M | $106.9M |
总债务CLVTDOC
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $9.8B | ||
| Q3 25 | $4.4B | $9.1B | ||
| Q2 25 | $4.5B | $9.0B | ||
| Q1 25 | $4.5B | $8.9B | ||
| Q4 24 | $4.5B | $8.7B | ||
| Q3 24 | $4.6B | $8.6B | ||
| Q2 24 | $4.6B | $8.6B |
股东权益CLVTDOC
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $7.5B | ||
| Q3 25 | $4.9B | $7.6B | ||
| Q2 25 | $5.0B | $7.9B | ||
| Q1 25 | $5.0B | $8.2B | ||
| Q4 24 | $5.1B | $8.4B | ||
| Q3 24 | $5.5B | $8.6B | ||
| Q2 24 | $5.6B | $8.8B |
总资产CLVTDOC
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $20.3B | ||
| Q3 25 | $11.2B | $19.6B | ||
| Q2 25 | $11.4B | $19.8B | ||
| Q1 25 | $11.5B | $19.8B | ||
| Q4 24 | $11.5B | $19.9B | ||
| Q3 24 | $12.0B | $20.0B | ||
| Q2 24 | $12.1B | $20.2B |
负债/权益比CLVTDOC
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 1.31× | ||
| Q3 25 | 0.90× | 1.20× | ||
| Q2 25 | 0.90× | 1.14× | ||
| Q1 25 | 0.90× | 1.08× | ||
| Q4 24 | 0.88× | 1.04× | ||
| Q3 24 | 0.84× | 1.00× | ||
| Q2 24 | 0.83× | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $357.0M |
| 自由现金流率自由现金流/营收 | 13.5% | 49.6% |
| 资本支出强度资本支出/营收 | 9.5% | 124.4% |
| 现金转化率经营现金流/净利润 | — | 10.99× |
| 过去12个月自由现金流最近4个季度 | $333.9M | — |
8季度趋势，按日历期对齐
经营现金流CLVTDOC
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $1.3B | ||
| Q3 25 | $181.1M | $315.0M | ||
| Q2 25 | $116.3M | $363.5M | ||
| Q1 25 | $171.2M | $279.4M | ||
| Q4 24 | $141.3M | $1.1B | ||
| Q3 24 | $202.9M | $318.2M | ||
| Q2 24 | $126.2M | $316.2M |
自由现金流CLVTDOC
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $357.0M | ||
| Q3 25 | $115.5M | — | ||
| Q2 25 | $50.3M | — | ||
| Q1 25 | $110.3M | — | ||
| Q4 24 | $59.1M | $333.7M | ||
| Q3 24 | $126.3M | — | ||
| Q2 24 | $60.3M | — |
自由现金流率CLVTDOC
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | 49.6% | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 8.9% | 47.8% | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 9.3% | — |
资本支出强度CLVTDOC
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 124.4% | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 12.4% | 105.6% | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 10.1% | — |
现金转化率CLVTDOC
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 10.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.48× | ||
| Q1 25 | — | 6.52× | ||
| Q4 24 | — | 235.43× | ||
| Q3 24 | — | 3.71× | ||
| Q2 24 | — | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
DOC
暂无分部数据
